Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Type 1 Diabetes with Actrapid HM in High Risk Relatives
NCT00654121Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2000
- Primary completion
- Apr 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of regular human insulin in type 1 diabetes mellitus (T1D), sponsored by AstraZeneca. Started Feb 2000; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00654121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00654121.